Skip to main content

Text Size

  • Increase
  • Decrease

Current Size: 100%

TNM Frequently Asked Questions

The TNM Project Committee receives questions concerning the use of TNM and how to interpret rules in specific situations. Categories that are included in our FAQ document are below and the questions and answers are downloadable for your convenience.

General questions

  • 1.1 In situ carcinoma
  • 1.2 High-grade dysplasia and carcinoma in situ
  • 1.3 Clinical and pathological stage
  • 1.4 R Classification
  • 1.5 R Classification and Tis
  • 1.6 Positive Cytology
  • 1.7 T0 and TX
  • 1.8 Synchronous tumours
  • 1.9 Single tumour cells and micrometastasis in lymph nodes
  • 1.10 Number of lymph nodes
  • 1.11 Pathological assessment of distant metastasis
  • 1.12 Classification of brain tumours
  • 1.13 Classification of primary peritoneal neoplasms
  • 1.14 Pathological versus clinical TNM
  • 1.15 When in doubt
  • 1.16 Tumour cells in lymphatics
  • 1.17 Tumour spillage
  • 1.18 Simultaneous tumours
  • 1.19 Direct spread
  • 1.20 N versus M
  • 1.21 Recurrent tumour
  • 1.22 Unknown primary
  • 1.23 Neo-adjuvant therapy
  • 1.24 AJCC versus UICC TNM
  • 1.25 Sentinel lymph node

Site-specific questions

  • 2.1 Larynx
  • 2.2 Oesophagus
  • 2.3 Colon and rectum
  • 2.4 Stomach
  • 2.4.1 In gastric carcinoma, is the presence of positive lymph nodes/tumour nodules in omentum considered N or M1?
  • 2.5 Pancreas
  • 2.6 Ampulla of Vater
  • 2.7 Lung
  • 2.8 Breast
  • 2.9 Corpus uteri
  • 2.10 Ovary versus uterus
  • 2.11 Ovary
  • 2.12 Prostate
  • 2.13 Penis
  • 2.14 Testis
  • 2.15 Kidney
  • 2.16 Urinary bladder

Attached files